Fresenius SE & Co saw the highest growth of 1.59% in patent filings in May and 2.08% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.24% and grants by 2.08%. GlobalData’s DataBook provides a comprehensive analysis of Fresenius SE & Co’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Fresenius SE & Co has been focused on protecting inventions in United States(US) with 32 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 37% filings and 41% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and China(CN) patent Office are among the top ten patent offices where Fresenius SE & Co is filings its patents. Among the top granted patent authorities, Fresenius SE & Co has 41% of its grants in United States(US), 26% in European Patent Office(EPO) and 11% in China(CN).
Taiwan Mitochondrion Applied Technology and Terumo could be the strongest competitors for Fresenius SE & Co
In terms of grant share, Fresenius SE & Co stands first among its competitors followed by Taiwan Mitochondrion Applied Technology and Terumo.
Patents related to healthtech and remote patient monitoring lead Fresenius SE & Co's portfolio
Fresenius SE & Co has the highest number of patents in healthtech followed by, remote patient monitoring and smart hospitals. For healthtech, nearly 22% of patents were filed and 13% of patents were granted in Q2 2024.
Drug delivery devices related patents lead Fresenius SE & Co portfolio followed by healthcare it, and other remote patient monitoring
Fresenius SE & Co has highest number of patents in drug delivery devices followed by healthcare it, other remote patient monitoring, nephrology and urology devices, and packaging. For drug delivery devices, nearly 11% of patents were filed and 8% of patents were granted in Q2 2024.
For comprehensive analysis of Fresenius SE & Co's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
